These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28076722)

  • 41. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
    Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
    J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
    Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
    J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
    Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
    Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
    Pozeg P; Forget J; Meuli RA; Maeder P
    Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spatiotemporal Pattern of Gadodiamide-Related T1 Hyperintensity Increase Within the Deep Brain Nuclei.
    Marie GPO; Pozeg P; Meuli RA; Maeder P; Forget J
    Invest Radiol; 2018 Dec; 53(12):748-754. PubMed ID: 30036232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
    Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
    Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
    Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
    Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global and Regional Brain Assessment with Quantitative MR Imaging in Patients with Prior Exposure to Linear Gadolinium-based Contrast Agents.
    Kuno H; Jara H; Buch K; Qureshi MM; Chapman MN; Sakai O
    Radiology; 2017 Apr; 283(1):195-204. PubMed ID: 27797676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Impact of Different Magnetic Resonance Imaging Equipment and Scanning Parameters on Signal Intensity Ratio Measurements in Phantoms and Healthy Volunteers: Implications for Interpreting Gadolinium Signal Changes Within the Brain.
    Young LK; Gandy SJ; Priba L; Matthew SZ; Graeme Houston J
    Invest Radiol; 2019 Mar; 54(3):169-176. PubMed ID: 30394963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
    Zivadinov R; Bergsland N; Hagemeier J; Ramasamy DP; Dwyer MG; Schweser F; Kolb C; Weinstock-Guttman B; Hojnacki D
    Neurology; 2019 Aug; 93(6):e611-e623. PubMed ID: 31285398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dentate Nucleus Signal Intensity Increases Following Repeated Gadobenate Dimeglumine Administrations: A Retrospective Analysis.
    Nguyen NC; Molnar TT; Cummin LG; Kanal E
    Radiology; 2020 Jul; 296(1):122-130. PubMed ID: 32343210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.
    Koiso T; Yamamoto M; Watanabe S; Barfod BE
    Neuroradiol J; 2019 Jun; 32(3):215-224. PubMed ID: 30924388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
    Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
    Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
    Ozturk K; Nascene D
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
    Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
    Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
    Krug KB; Burke CJ; Weiss K; Baltzer PAT; Rhiem K; Maintz D; Schlamann M; Hellmich M
    Eur Radiol; 2022 Jan; 32(1):331-345. PubMed ID: 34218287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents.
    Kang H; Hii M; Le M; Tam R; Riddehough A; Traboulsee A; Kolind S; Freedman MS; Li DKB
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1597-1603. PubMed ID: 30139752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does MR arthrography cause intracranial gadolinium deposition?
    Bunnell KM; Hemke R; Husseini JS; Torriani M; Huang SY; Bredella MA
    Skeletal Radiol; 2020 Jul; 49(7):1051-1056. PubMed ID: 31982970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.